Brainstorm Cell Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$17,192,000 over the previous period. Total operating expenses were $21,174,000.

Profit Margin

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI): Profit margin
2012 0 -3.43M
2013 0 -4.89M
2014 0 -9.24M
2016 0 -4.98M
2018 0 -13.83M
2019 -366K -23.50M 6422.13%
2020 0 -31.93M
2021 0 -24.37M
2022 0 -23.73M
2023 0 -17.19M

BCLI Income Statement (2012 – 2023)

2023 2022 2021 2020 2019 2018 2016 2014 2013 2012
Revenue
Revenue
0000-366K00000
Cost of revenue
265K285K260K219K366K110K77K000
Gross profit
-265K-285K-260K-219K-732K-110K-77K000
Operating exp.
Research and development
10.48M13.95M15.23M22.32M17.20M8.29M2.25M4.77M2.91M1.77M
Selling and marketing
0000000000
Total operating expenses
21.17M24.82M24.53M31.68M23.00M14.06M5.08M7.42M5.01M3.51M
Operating income
-21.43M-24.82M-24.53M-31.68M-23.00M-14.06M-5.08M-7.42M-4.87M-3.42M
Other income (expenses), net
4.24M545K82K-127K-252K115K101K-1.82M00
Income before tax
-17.19M-24.27M-24.45M-31.81M-23.25M-13.94M-4.98M-9.24M-4.87M-3.42M
Income tax expense
0-545K-82K127K252K-115K-101K-1.82M25K5K
Net income
-17.19M-23.73M-24.37M-31.93M-23.50M-13.83M-4.98M-9.24M-4.89M-3.43M
Earnings per share
Basic EPS
-0.4-0.65-0.67-1.07-1.07-0.69-0.27-0.68-0.46-0.29
Diluted EPS
-0.4-0.65-0.67-1.07-1.07-0.69-0.27-0.68-0.46-0.29
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source